Techstars Startup Week Dayton 2019 has ended
avatar for Michael Triplett

Michael Triplett

Carmen Partners
New Albany
Dr. Michael Triplett is Principal at Carmen Partners LLC, a life sciences focused venture development, strategy, and innovation consultancy.  Dr. Triplet co-founded and served as President and CEO of Myonexus Therapeutics, a clinical stage gene therapy biotechnology company developing first-ever treatments for limb-girdle muscular dystrophies that sold to Sarepta Therapeutics in 2019.    

Exceling at the interfaces of disparate business functions and technical subject domains, Dr. Triplett brings unique and actionable insights to organizations, resulting in transformative venture opportunities, growth strategies, and pioneering innovations. Dr. Triplett is passionate about technology commercialization and new venture development, corporate strategy, innovation, technology-based economic development, and science, technology, engineering and math (STEM) education.

My Speakers Sessions

Wednesday, June 5

8:30am PDT